Anne F. Luetkemeyer

Statistics

Publications

Citations

6.6K

H-Index

Active since

2005

Affiliations

University of California, San Francisco(Current)

San Francisco General Hospital

Harvard University

University of Washington

Johns Hopkins University

Anne F. Luetkemeyer is an author at University of California, San Francisco specializing in infectious diseases, antiviral therapy, and pharmacotherapy.

ORCID

Publications per year

2005–2025

Publications

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

Diane V. Havlir, Michelle A. Kendall, Prudence Ive et al. · New England Journal of Medicine · 2011 · 538 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

Susanna Naggie, Curtis Cooper, Michael S. Saag et al. · New England Journal of Medicine · 2015 · 467 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections

Anne F. Luetkemeyer, Deborah Donnell, Julia C. Dombrowski et al. · New England Journal of Medicine · 2023 · 439 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +17

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

David Wyles, Peter Ruane, Mark Sulkowski et al. · New England Journal of Medicine · 2015 · 422 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

1–5 of 60